Fed. Circ. OKs Order Blocking Generic Of Allergan Eye Drug
The Federal Circuit on Thursday left in place an order preventing Novartis' Sandoz division from launching a generic version of Allergan's Combigan eye drug, rejecting arguments that a lower court misinterpreted...To view the full article, register now.
Already a subscriber? Click here to view full article